|
Dr. John Holaday is the Managing Director, President and CEO; founding Director of QRxPharma (QRX, ASX), a specialty pharmaceutical company headquartered in Sydney, Australia. He served as co-founder of HarVest Bank of Maryland, EntreMed, Inc. (ENMD, NASDAQ) in 1992, Medicis Pharmaceutical Corp. (MRX, NYSE) in 1988. He also founded MaxCyte, Inc. and is on the boards of Qbit, CytImmune Sciences, Xceleron, Accelovance and Seno Medical. He has raised over $360MM in private and public rounds of financing for these companies that have a collective market capitalization in excess of over $2 billion. Dr. Holaday served as a Captain in the US Army, and was at the Walter Reed Army Institute of Research as an officer and civilian for 21 years. Dr. Holaday obtained his BS (1966) and MS (1968) from the University of Alabama (UofA), and his PhD from the University of California, San Francisco in 1976. He was Professor of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine (until 1996) and is Professor of Psychiatry at the Uniformed Services University of the Health Sciences. He is former Chair of the BioAlliance of the Tech Council of Maryland, and serves on the Board of that organization and the MdBio Foundation. Dr. Holaday serves on the Leadership Board for the College of Arts and Sciences, UofA, the Leadership Board of the University of Maryland Biotechnology Institute, and the Judges Panel for the Ernst and Young Entrepreneur of the Year (2003-present). Dr. Holaday is on the Advisory Board of Harbert Investments; he was named to the Ernst&Young's Entrepreneur of the Year 2006 Hall of Fame, holds over 30 patents and published over 200 scientific articles and five books. | 